Giovanna Piscopo

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts.

Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts.

Journal: Environmental toxicology and pharmacology

Published: September 27, 2018

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity.

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity.

Journal: Nutrients

Published: August 10, 2018

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

Journal: Frontiers in physiology

Published: November 27, 2017

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.

Journal: Cancer treatment reviews

Published: June 29, 2017

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.

Journal: OncoTargets and therapy

Published: November 16, 2016

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: May 17, 2016

Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.

Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: May 17, 2016

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?

Journal: Human vaccines & immunotherapeutics

Published: February 03, 2016

WITHDRAWN:A Practical Approach for Management of QT Prolongation Induced by Anticancer Drugs.

WITHDRAWN:A Practical Approach for Management of QT Prolongation Induced by Anticancer Drugs.

Journal: The oncologist

Published: August 07, 2015

Proposal of a new method for the use of the Rydel-Seiffer tuning fork in the screening of diabetic polyneuropathy. A pilot study.

Proposal of a new method for the use of the Rydel-Seiffer tuning fork in the screening of diabetic polyneuropathy. A pilot study.

Journal: Diabetes research and clinical practice

Published: August 01, 2014

Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.

Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.

Journal: European journal of heart failure

Published: July 31, 2013

The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.

The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.

Journal: European journal of heart failure

Published: January 18, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026